Manipulating angiogenesis against vascular disease.
- 15 June 1999
- journal article
- review article
- Published by Taylor & Francis in Hospital Practice
- Vol. 34 (6) , 69-86
- https://doi.org/10.3810/hp.1999.06.147
Abstract
Gene therapy to stimulate the growth of new blood vessels is proving to be an effective way of bypassing occluded arteries and reestablishing blood flow to ischemic tissues. It could eventually replace surgical revascularization and angioplasty, which are not only more invasive but also plagued with restenosis, problems limiting long-term management of coronary artery and peripheral vascular disease.Keywords
This publication has 6 references indexed in Scilit:
- Gene Therapy for Myocardial AngiogenesisCirculation, 1998
- Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothelial growth factor: Preliminary clinical resultsJournal of Vascular Surgery, 1998
- Constitutive Expression of phVEGF 165 After Intramuscular Gene Transfer Promotes Collateral Vessel Development in Patients With Critical Limb IschemiaCirculation, 1998
- Arterial gene transfer of naked DNA for therapeutic angiogenesis: early clinical resultsAdvanced Drug Delivery Reviews, 1998
- Therapeutic angiogenesisFrontiers in Bioscience-Landmark, 1998
- Local Delivery of Vascular Endothelial Growth Factor Accelerates Reendothelialization and Attenuates Intimal Hyperplasia in Balloon-Injured Rat Carotid ArteryCirculation, 1995